Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2026-03-12 @ 2:43 AM
Study NCT ID:
NCT01838018
Status:
COMPLETED
Last Update Posted:
2018-05-29
First Post:
2013-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Sponsor:
Susan J. Hayflick
Organization:
Study Overview
Official Title:
Brain Perfusion in Pantothenate Kinase-Associated Neurodegeneration (PKAN)
Status:
COMPLETED
Status Verified Date:
2018-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to learn whether blood flow in the brain is normal in people with pantothenate kinase-associated neurodegeneration (PKAN). Specifically, preliminary data suggest a region of the brain called the globus pallidus (GP), a key region affected by PKAN, may have reduced blood flow. Standard MRI and perfusion scanning techniques will be used to learn about cerebral blood flow in the globus pallidus and compare it to blood flow in other brain regions as well as to healthy controls.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: